Table 4.
Treatment | Final body weight (g) | Number of papilloma | Tumor size | Average latency perioda |
---|---|---|---|---|
Group 1 | 37.56 ± 5.43* | |||
Group 2 | 22.75 ± 11.24 | 10.16 ± 5.03 | 2.06 ± 0.37 | 10.10 ± 5.17 |
Group 3 | 36.96 ± 6.31* | |||
Group 4 | 38.87 ± 9.67* | 1.50 ± 1.04* | 0.90 ± 0.29* | 15.73 ± 0.58* |
Group 5 | 40.12 ± 6.89* | 0.83 ± 0.75* | 0.56 ± 0.22* | 18.16 ± 0.55* |
Values with * superscripts were significant (P < 0.05) in comparison with Group 2.
aThe lag between the application of the promoting agent and the appearance of 50% of tumors was determined. Average latency period = ∑fx/n; f is the number of tumors appearing each week; x is the numbers of weeks; and n is the total number of tumors.